An open label, pilot study to determine the effect of in-centre and at-home administration intra-cavernosal injections of Invicorp on male Erectile Dysfunction (ED) post radical prostatectomy
Latest Information Update: 02 Jul 2024
At a glance
- Drugs Aviptadil/phentolamine (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors RestoriT
- 18 Jun 2024 Status changed from active, no longer recruiting to completed.
- 16 Jun 2023 Planned End Date changed from 30 Jun 2023 to 1 Jun 2027.
- 16 Jun 2023 Status changed from recruiting to active, no longer recruiting.